Singapore-based startup Albatroz secures $3 M to develop solid tumour therapy

… Golden Ticket winner in Singapore Albatroz Therapeutics, a Singapore-based biotechnology startup … of therapeutic antibodies against a novel target that degrades the extracellular … the exciting discovery of a novel and broadly distributed target present …